Dexmedetomidine /kg/h

PreclinicalSmall molecule

Dexmedetomidine /kg/h is one of 3 small molecule programs targeting PTSD - Post Traumatic Stress Disorder. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PTSD - Post Traumatic Stress DisorderRecruiting

PTSD - Post Traumatic Stress DisorderPreclinical

Recruiting

Competition

Competitive Landscape

3 competitors in PTSD - Post Traumatic Stress Disorder

#DrugCompanyPhaseTrials

Belsomra

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Approved

1 2

D-Cycloserine

MMassachusetts General Hospital

Phase 2

2 3

Dexmedetomidine /kg/h

UUniversity Hospital Dubrava

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

PreclinicalRecruiting

PTSD - Post Traumatic Stress Disorder

NCT07813962

Clinical

Trials by Indication[1]

Completed·SSoutheast University, China·Phase 4·NCT02270281·44 enrolled

Aortic Valve Replacement1 trial

Evaluation of Intraoperative Dexmedetomidine Use in Patients Undergoing Surgical Aortic Valve Replacement

Completed·UUniversity Hospital Dubrava·Phase 3·NCT05641064·60 enrolled

PTSD - Post Traumatic Stress Disorder1 trial

Dexmedetomidine Combined With Transcutaneous Vagus Nerve Stimulation (taVNS) for the Prevention of Post-traumatic Stress Disorder (PTSD) in Patients Undergoing Emergency Trauma Surgery

Recruiting·AAffiliated Hospital of Nantong University·Preclinical·NCT07813962·300 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Dexmedetomidine /kg/h. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Dexmedetomidine /kg/h compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Dexmedetomidine /kg/h. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital Dubrava company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity Hospital Dubrava

Dexmedetomidine /kg/h

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

One-lung Ventilation1 trial

Cesarean Section1 trial

Septic Shock1 trial

Aortic Valve Replacement1 trial

PTSD - Post Traumatic Stress Disorder1 trial

References

Drug Info

Quick Facts

Related News